Immune to Cancer: The CRI Blog
-
ASCO18 Update: Much Ado About Melanoma (and Lung Cancer, Too)
Day 4 of ASCO18 focused on the past, present, and future of melanoma treatment, and also revealed…
-
ASCO18 Update: Immunotherapy Progress in Lung Cancer, New Promise in Ovarian Cancer
Day 3 of ASCO18 revealed more of immunotherapy’s benefits in lung cancer, especially as a first-line option,…
-
ASCO18 Update: Enhancing the Immune System’s Power Through Combination Therapies
Day 2 of ASCO18 highlighted a number of combinations and novel agents that aimed to improve immunotherapy’s…
-
ASCO18 Update: Vaccines, CAR T Cells, and OX40 Checkpoint Therapy
The first day of ASCO18 highlighted diverse immunotherapies, including vaccines, CAR T cells, and novel checkpoint drugs
-
ASCO18: Delivering Discoveries – Expanding the Reach of Precision Medicine
The world’s largest clinical cancer conference returns to Chicago June 1-5
-
ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference
ASCO17’s presentations reveal that the field of immunotherapy is advancing along many fronts
-
ASCO17: Days 4 and 5 Immunotherapy Highlights
Days 4 and 5 at ASCO17 showed off the overall scope of immunotherapy’s efforts to provide clinical…
-
ASCO17: Day 3 Immunotherapy Highlights
Day 3 at the 2017 annual meeting of the American Society of Clinical Oncology touched on immunotherapy…
-
ASCO17: Day 2 Immunotherapy Highlights
Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's…